DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Afluria (Influenza Virus Vaccine) - Current Clinical Trials

 
 



Afluria Related Clinical Trials

School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities [Completed]

Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects [Completed]

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM [Completed]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) [Completed]

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. [Completed]

Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults [Completed]

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Completed]

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years [Completed]

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza [Completed]

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 [Completed]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine [Completed]

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years [Completed]

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects [Completed]

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine [Completed]

Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [Completed]

Study of Quadrivalent Influenza Vaccine Among Adults [Completed]

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults [Completed]

2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [Completed]

Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old [Completed]

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults [Completed]

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine [Active, not recruiting]

A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age [Completed]

Trial to Collect Safety Data and Sera for Immunogenicity Testing [Completed]

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021)- Year 1, 2011 [Active, not recruiting]

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children [Completed]

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) [Active, not recruiting]

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season [Recruiting]

Influenza Vaccine in Pregnant Women [Completed]

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households [Completed]

Study of Quadrivalent Influenza Vaccine Among Children [Completed]

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza [Completed]

Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age [Completed]

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women [Completed]

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age [Completed]

A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children [Completed]

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age [Completed]

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults [Completed]

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting [Completed]

Safety Study of FluMist With and Without Ampligen [Recruiting]

The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis [Recruiting]

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents [Completed]

Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally [Completed]

Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal [Completed]

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A [Completed]

Brief Influenza Vaccine Education to Pregnant Women [Active, not recruiting]

Maternal Flu Vaccine Trial in Bamako, Mali [Active, not recruiting]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older [Completed]

Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers [Active, not recruiting]

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine [Completed]

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults [Completed]

Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus [Completed]

Revaccination With Influenza Vaccine GSK1247446A [Completed]

A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older [Completed]

Two-site Intradermal Influenza Vaccination in Elderly [Recruiting]

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months [Completed]

High Dose Influenza Vaccine in Nursing Home [Active, not recruiting]

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine [Completed]

T-cell And General Immune Response to Seasonal Influenza Vaccine(SLVP018) [Active, not recruiting]

Immune Responses to the Flu Shot During Pregnancy [Recruiting]

Seasonal Influenza Vaccine Effectiveness Study in Kenya [Recruiting]

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Completed]

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children [Completed]

Field Trial of Maternal Influenza Immunization in Asia [Recruiting]

Impact of Influenza Vaccination in Pregnancy Video Education [Completed]

Influenza Vaccine in HIV Infected Children [Completed]

Influenza Immunization of Children in India [Active, not recruiting]

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015